Benefits and perks at Erasca
Erasca hasn't added any benefits
If you work at Erasca, you can claim your profile and add your tech stack.
Discover the employees benefits and perks available to Erasca employees.
If you work at Erasca, you can claim your profile and add your tech stack.
51-200 employees
2020
Jonathan E. Lim, M.D.
Try our AI resume builder, interview practice, and cover letter generator for free. Then, unlock unlimited use for just $9/month.
View all toolsExplore the variety of open remote roles at Erasca, offering flexible work options across multiple disciplines and skill levels.
Find your next opportunity by exploring profiles of companies that are similar to Erasca. Compare culture, benefits, and job openings on Himalayas.
Sign up now and join over 85,000 remote workers who receive personalized job alerts, curated job matches, and more for free!
Sign up now and join over 85,000 remote workers who receive personalized job alerts, curated job matches, and more for free!
Find your next opportunity by exploring profiles of companies that are similar to Erasca. Compare culture, benefits, and job openings on Himalayas.
Scorpion Therapeutics is a pioneering clinical-stage company dedicated to developing precision oncology therapies that target underlying genetic drivers of cancer.
Kura Oncology is focused on developing targeted therapies for cancer with an emphasis on precision medicine.
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on developing innovative therapies for cancer treatment.
Nuvalent is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.
Nurix Therapeutics, Inc. is a biotechnology company dedicated to developing targeted protein degradation therapies for cancer and autoimmune disorders.
Foghorn Therapeutics is revolutionizing the treatment of serious diseases by correcting gene expression through innovative therapeutics.